Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in RAPP — Rapport Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,284,781
+$2,777,779 QoQ
Shares Held
246,815
+2.9% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 159 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. RAPP ranks #106 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in RAPP

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,284,781 246,815
2026-03-31 $7,507,002 239,917
2025-12-31 $7,414,822 244,391
2025-09-30 $6,012,735 202,449
2025-06-30 $1,063,060 93,497
2025-03-31 $912,409 90,968
2024-12-31 $1,304,049 73,509
2024-09-30 $1,498,030 73,146